company-logo

SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including recurrent VVC, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections; and ibrexafungerp that has completed Phase 3 CANDLE study for the prevention of recurrent (VVC). It has research collaborations with Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC to develop and commercialize rights for ibrexafungerp. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.

SCYNEXIS Dividend Announcement

SCYNEXIS does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on SCYNEXIS dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

SCYNEXIS Dividend Yield

SCYNEXIS current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing SCYNEXIS stock? Use our calculator to estimate your expected dividend yield:

SCYNEXIS Financial Ratios

P/E ratio-1.81
PEG ratio-0.21
P/B ratio1.06
ROE-47.27%
Payout ratio0.00%
Current ratio3.75
Quick ratio3.75
Cash Ratio1.05

SCYNEXIS Dividend FAQ

Does SCYNEXIS stock pay dividends?
SCYNEXIS does not currently pay dividends to its shareholders.
Has SCYNEXIS ever paid a dividend?
No, SCYNEXIS has no a history of paying dividends to its shareholders. SCYNEXIS is not known for its dividend payments.
Why doesn't SCYNEXIS pay dividends?
There are several potential reasons why SCYNEXIS would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will SCYNEXIS ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While SCYNEXIS has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is SCYNEXIS a dividend aristocrat?
SCYNEXIS is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is SCYNEXIS a dividend king?
SCYNEXIS is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is SCYNEXIS a dividend stock?
No, SCYNEXIS is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy SCYNEXIS stocks?
To buy SCYNEXIS you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy SCYNEXIS stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.